A new fluoride mediated synthesis of mesoporous silica and their usefulness in controlled delivery of duloxetine hydrochloride a serotonin re-uptake inhibitor
-
Add time:09/29/2019 Source:infona.pl
A new type of mesoporous silica nanoparticle (MSN) was synthesized in fluoride media via sol–gel technique using TritonX 100 and Tween-20. The surface area and pore volume of the MSN particles were modified by varying the concentration of Tween-20. The prepared MSN nanoparticles with large surface area and pore volume (T-2, T-3) were selected to accommodate the model drug duloxetine hydrochloride (DX) for evaluation of their drug-loading and release abilities. Calcined and DX loaded nanoparticles were characterized by Brunauer–Emmett–Teller technique (BET), powder X-ray diffraction (XRD), scanning electron microscopy (SEM), thermogravimetric (TG) analysis and UV-diffuse reflectance (UV-DRS). In vitro release studies proved that the particle displays an initial burst release followed by sustained release for up to 140h. From the studies it is evident that the synthesized particle may be useful as a carrier for sustained release of active pharmaceutical ingredients (APIs).
We also recommend Trading Suppliers and Manufacturers of Serotonin hydrochloride (cas 153-98-0). Pls Click Website Link as below: cas 153-98-0 suppliers
Prev:Involvement of dopamine (DA)/serotonin (5-HT)/sigma (σ) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist
Next:Exposures to a selective serotonin reuptake inhibitor (SSRI), sertraline hydrochloride, over multiple generations: Changes in life history traits in Ceriodaphnia dubia) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Exposures to a selective serotonin reuptake inhibitor (SSRI), sertraline hydrochloride, over multiple generations: Changes in life history traits in Ceriodaphnia dubia09/30/2019
- Involvement of dopamine (DA)/serotonin (5-HT)/sigma (σ) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist09/28/2019
-
Health and Chemical more >


